Prognostic factors for survival in patients with Ewing's sarcoma using the surveillance, epidemiology, and end results (SEER) program database

Cancer Epidemiology

Volumn 39, Issue 2, 2015, Pages 189-195

  Duchman, Kyle R ^a   Gao, Yubo ^a   Miller, Benjamin J ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Bone neoplasms mortality; Ewing mortality; Risk factors; Sarcoma; SEER program: survival rate; Survival analysis

Indexed keywords

ADULT; ARTICLE; BLACK PERSON; CANCER EPIDEMIOLOGY; CANCER PROGNOSIS; CANCER REGISTRY; CANCER SIZE; CANCER SURVIVAL; CAUSE SPECIFIC SURVIVAL; EWING SARCOMA; FEMALE; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; YOUNG ADULT; COHORT ANALYSIS; MORTALITY; PATHOLOGY; PROGNOSIS; RISK FACTOR; SURVIVAL;

ADULT; COHORT STUDIES; FEMALE; HUMANS; MALE; PROGNOSIS; RISK FACTORS; SARCOMA, EWING; SEER PROGRAM; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84926174921     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2014.12.012     Document Type: Article

References (35)

1. Cotterill S., Parker L., Malcolm A., Reid M., More L., Craft A. Incidence and survival for cancer in children and young adults in the North of England, 1968-1995: a report from the Northern Region Young Persons' Malignant Disease Registry. Br J Cancer 2000, 83:397.
2. Jaffe N., Paed D., Traggis D., Salian S., Cassady J.R. Improved outlook for Ewing's sarcoma with combination chemotherapy (vincristine, actinomycin D and cyclophosphamide) and radiation therapy. Cancer 1976, 38:1925-1930.
3. Ewing J. Diffuse endothelioma of bone. CA Cancer J Clin 1972, 22:95-98.
4. Phillips R.F., Higinbotham N.L. The curability of Ewing's endothelioma of bone in children. J Pediatr 1967, 70:391-397.
5. Arpaci E., Yetisyigit T., Seker M., Uncu D., Uyeturk U., Oksuzoglu B., et al. Prognostic factors and clinical outcome of patients with Ewing's sarcoma family of tumors in adults: multicentric study of the Anatolian Society of Medical Oncology. Med Oncol 2013, 30:1-7.
6. Bacci G., Ferrari S., Bertoni F., Rimondini S., Longhi A., Bacchini P., et al. Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico Rizzoli. J Clin Oncol 2000, 18:4-11.
7. Bacci G., Longhi A., Ferrari S., Mercuri M., Versari M., Bertoni F. Prognostic factors in non-metastatic Ewing's sarcoma tumor of bone: an analysis of 579 patients treated at a single institution with adjuvant or neoadjuvant chemotherapy between 1972 and 1998. Acta Oncol 2006, 45:469-475.
8. Esiashvili N., Goodman M., Marcus R.B. Changes in incidence and survival of Ewing sarcoma patients over the past 3 decades: Surveillance Epidemiology and End Results data. J Pediatr Hematol Oncol 2008, 30:425-430.
9. Gaspar N., Rey A., Bérard P.M., Michon J., Gentet J.C., Tabone M.D., et al. Risk adapted chemotherapy for localised Ewing's sarcoma of bone: the French EW93 study. Eur J Cancer 2012, 48:1376-1385.
10. Lopez Guerra J.L., Marquez-Vega C., Ramirez-Villar G.L., Cabrera P., Ordonez R., Praena-Fernandez J.M., et al. Prognostic factors for overall survival in paediatric patients with Ewing sarcoma of bone treated according to multidisciplinary protocol. Clin Transl Oncol 2012, 14:294-301.
11. Jawad M.U., Cheung M.C., Min E.S., Schneiderbauer M.M., Koniaris L.G., Scully S.P. Ewing sarcoma demonstrates racial disparities in incidence-related and sex-related differences in outcome. Cancer 2009, 115:3526-3536.
12. Lee J., Hoang B.H., Ziogas A., Zell J.A. Analysis of prognostic factors in Ewing sarcoma using a population-based cancer registry. Cancer 2010, 116:1964-1973.
13. Miller B.J., Lynch C.F., Buckwalter J.A. Conditional survival is greater than overall survival at diagnosis in patients with osteosarcoma and Ewing's sarcoma. Clin Orthop Relat Res 2013, 471:3398-3404.
14. O'Connor M.I., Pritchard D.J. Ewing's sarcoma: prognostic factors, disease control, and the reemerging role of surgical treatment. Clin Orthop Relat Res 1991, 262:78-87.
15. Wilkins R.M., Pritchard D.J., Omer E.B., Unni K.K. Ewing's sarcoma of bone. Experience with 140 patients. Cancer 1986, 58:2551-2555.
16. Paulussen M., Ahrens S., Dunst J., Winkelmann W., Exner G., Kotz R., et al. Localized Ewing tumor of bone: final results of the cooperative Ewing's Sarcoma Study CESS 86. J Clin Oncol 2001, 19:1818-1829.
17. Cotterill S., Ahrens S., Paulussen M., Jürgens H., Voute P., Gadner H., et al. Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group. J Clin Oncol 2000, 18:3108-3114.
18. Cangir A., Vietti T.J., Gehan E.A., Burgert E.O., Thomas P., Tefft M., et al. Ewing's sarcoma metastatic at diagnosis results and comparisons of two intergroup Ewing's sarcoma studies. Cancer 1990, 66:887-893.
19. Paulussen M., Ahrens S., Burdach S., Craft A., Dockhorn-Dworniczak B., Dunst J., et al. Primary metastatic (stage IV) Ewing tumor: survival analysis of 171 patients from the EICESS studies. Ann Oncol 1998, 9:275-281.
20. Du X.L., Fang S., Coker A.L., Sanderson M., Aragaki C., Cormier J.N., et al. Racial disparity and socioeconomic status in association with survival in older men with local/regional stage prostate carcinoma. Cancer 2006, 106:1276-1285.
21. Miller B.J., Cram P., Lynch C.F., Buckwalter J.A. Risk factors for metastatic disease at presentation with osteosarcoma: an analysis of the SEER database. J Bone Joint Surg Am 2013, 95:e891-e898.
22. Sun M., Abdollah F., Liberman D., Abdo A., Thuret R., Tian Z., et al. Racial disparities and socioeconomic status in men diagnosed with testicular germ cell tumors. Cancer 2011, 117:4277-4285.
23. Gupta A.A., Pappo A., Saunders N., Hopyan S., Ferguson P., Wunder J., et al. Clinical outcome of children and adults with localized Ewing sarcoma. Cancer 2010, 116:3189-3194.
24. Verrill M., Judson I., Wiltshaw E., Thomas J., Harmer C., Fisher C. The use of paediatric chemotherapy protocols at full dose is both a rational and feasible treatment strategy in adults with Ewing's family tumours. Ann Oncol 1997, 8:1099-1105.
25. Karski E.E., Matthay K.K., Neuhaus J.M., Goldsby R.E., DuBois S.G. Characteristics and outcomes of patients with Ewing sarcoma over 40 years of age at diagnosis. Cancer Epidemiol 2013, 37:29-33.
26. Bacci G., Longhi A., Briccoli A., Bertoni F., Versari M., Picci P. The role of surgical margins in treatment of Ewing's sarcoma family tumors: experience of a single institution with 512 patients treated with adjuvant and neoadjuvant chemotherapy. Int J Radiat Oncol Biol Phys 2006, 65:766-772.
27. Polednak A.P. Primary bone cancer incidence in black and white residents of New York State. Cancer 1985, 55:2883-2888.
28. Crawford S.M., Sauerzapf V., Haynes R., Zhao H., Forman D., Jones A.P. Social and geographical factors affecting access to treatment of lung cancer. Br J Cancer 2009, 101:897-901.
29. Duchman K.R., Lynch C.F., Buckwalter J.A., Miller B.J. Estimated cause-specific survival continues to improve over time in patients with chondrosarcoma. Clin Orthop Relat Res 2014, 472(8):2516-2525.
30. Giuffrida A.Y., Burgueno J.E., Koniaris L.G., Gutierrez J.C., Duncan R., Scully S.P. Chondrosarcoma in the United States (1973 to 2003): an analysis of 2890 cases from the SEER database. J Bone Joint Surg Am 2009, 91:1063-1072.
31. Johnson D.R., Ma D.J., Buckner J.C., Hammack J.E. Conditional probability of long-term survival in glioblastoma. Cancer 2012, 118:5608-5613.
32. Bach P.B., Guadagnoli E., Schrag D., Schussler N., Warren J.L. Patient demographic and socioeconomic characteristics in the SEER-Medicare database: applications and limitations. Med Care 2002, 40:IV-19-IV-25.
33. Nattinger A.B., McAuliffe T.L., Schapira M.M. Generalizability of the surveillance, epidemiology, and end results registry population: factors relevant to epidemiologic and health care research. J Clin Epidemiol 1997, 50:939-945.
34. Krieger N., Chen J.T., Waterman P.D., Soobader M.-J., Subramanian S., Carson R. Geocoding and monitoring of US socioeconomic inequalities in mortality and cancer incidence: does the choice of area-based measure and geographic level matter? the Public Health Disparities Geocoding Project. Am J Epidemiol 2002, 156:471-482.
35. Subramanian S., Chen J., Rehkopf D., Waterman P., Krieger N. Comparing individual-and area-based socioeconomic measures for the surveillance of health disparities: a multilevel analysis of Massachusetts births, 1989-1991. Am J Epidemiol 2006, 164:823-834.